Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Access Control
LeftNav
Alarms
LeftNav
Biometrics
LeftNav
Detection
LeftNav
Deutsche Zone (German Zone)
LeftNav
Education, Training and Professional Services
LeftNav
Government Programmes
LeftNav
Guarding, Equipment and Enforcement
LeftNav
Industrial Computing Security
LeftNav
IT Security
LeftNav
Physical Security
LeftNav
Surveillance
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Manufacturing Zone
Pro Security Zone
Web Lec
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
ProSecurityZone Sponsor
 
 
News

Global strategy report on bioterrorism prevention

Global Industry Analysts : 25 June, 2009  (New Product)
Comprehensive report available from GIA on the market for bioterrorism detection equipment
Over the past few years, the US spending on bioweapon prevention and defence has been growing only modestly, unlike in the early part of this decade when the government allocated significant funds to counter bioterrorism. This has been projected as the primary factor for the growth of the US bioterrorism detection equipment market over the forecast period 2008-2015. The second largest market, trailing with a sizeable difference, is Europe where funding and programs for biodefence are not strong enough to provide substantial impetus for market growth.

On the other hand, Asia and the Middle East, though characterized with a small value base, show robust potential for growth. The attractiveness of the Middle East market stems from the volatility of the region and increased governmental interest in acquiring biological agent detection equipment.

The global marketplace is characterized by participants such as Acambis Plc, AVI BioPharma, Inc., Blücher GmbH, Evogen, Inc., Human Genome Sciences Inc., ICX Technologies, Inc., ILC Dover LP, Medarex, Inc., Northrop Grumman Corporation, PharmAthene, Inc., Scott Health & Safety, Smiths Detection, The Baker Company, and Universal Detection Technology. Additional market participants include Advanced Life Sciences Holdings, Inc., ADVNT Biotechnologies, BioFactura, Inc., Coley Pharmaceutical Group, Inc., Crucell, CytoGenix, Emergent BioSolutions, General Dynamics Canada, Gulf Security Solutions, Ibis Biosciences, Inc., Ichor Medical Systems, Innovative Biosensors, Inc., Integrated BioTherapeutics, IR BioSciences Holdings Inc., Kadinuo Science and Technology Company, Medison Pharma Ltd., NanoSensors, Inc., Nanotherapeutics, Inc., Omrix Biopharmaceuticals, Safe Life Corp., Security Solutions International, SRI International, U.S. BioDefense, Inc.

'Bioterrorism: A Global Strategic Business Report' announced by Global Industry Analysts, Inc. provides a comprehensive review of market drivers, product profile, players, competition, recent developments, mergers, acquisitions, and other strategic industry activities. Analysis is presented for major geographic markets such as the United States, Europe, Asia and the Middle East.

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProSecurityZone.com
Netgains Logo